VN1R82P: A Potential Drug Target and Biomarker (G100312827)

Target Name: VN1R82P

NCBI ID: G100312827

VN1R82P

Other Name(s): Vomeronasal 1 receptor 82 pseudogene | vomeronasal 1 receptor 82 pseudogene

VN1R82P: A Potential Drug Target and Biomarker

VN1R82P, also known as NNX142, is a small non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases.

The discovery of VN1R82P

VN1R82P was first identified using RNA sequencing (RNA-seq) technology as a highly expressed gene in the blood samples of individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The gene has since been shown to be highly expressed in the brains of individuals with these diseases, and has also been shown to be involved in the development of psychiatric disorders, such as depression and anxiety.

The function of VN1R82P

VN1R82P is a non-coding RNA that has been shown to play a role in the regulation of gene expression. It is expressed in a variety of tissues and cells and has been shown to interact with various protein partners, including the protein NHEJ.

One of the most significant functions of VN1R82P is its role in the regulation of gene expression. Studies have shown that VN1R82P can interact with various gene promoters and can modulate their activity. This may have implications for the regulation of cellular processes such as cell growth, differentiation, and inflammation.

In addition to its role in gene expression, VN1R82P has also been shown to play a role in the regulation of RNA stability. Studies have shown that VN1R82P can interact with the protein TRIM2 and promote the stability of certain RNA species, such as pre-mRNA. This may have implications for the regulation of gene expression and the development of various diseases.

The potential as a drug target

The potential of VN1R82P as a drug target is significant due to its unique structure and function. Its interaction with protein partners and its role in the regulation of gene expression and RNA stability suggest that it may be a useful target for the treatment of diseases that are characterized by the disruption of normal cellular processes, such as those associated with neurodegenerative diseases, psychiatric disorders, and cancer.

One potential mechanism by which VN1R82P may be targeted as a drug is its role in the regulation of cellular processes that are involved in the development and progression of these diseases. For example, the regulation of gene expression and RNA stability by VN1R82P may be disrupted in the brains of individuals with neurodegenerative diseases, leading to the expression of aberrant proteins and the disruption of cellular processes that contribute to the development and progression of these diseases.

In addition to its potential as a drug target, VN1R82P may also be a useful biomarker for the diagnosis and monitoring of these diseases. The regulation of gene expression and RNA stability by VN1R82P may be disrupted in the brains of individuals with neurodegenerative diseases, leading to the expression of aberrant proteins and the disruption of cellular processes that contribute to the development and progression of these diseases. The detection of these changes in gene expression and RNA stability could be used as a biomarker for the diagnosis and monitoring of these diseases.

Conclusion

VN1R82P is a small non-coding RNA that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a drug may have significant implications for the treatment of these diseases. Further studies are needed to fully understand the function of VN1R82P as a drug target and biomarker, and to determine its potential as a treatment for these diseases.

Protein Name: Vomeronasal 1 Receptor 82 Pseudogene

The "VN1R82P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VN1R82P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets